Tradestie Institutional Equity Comparison Engine

NMR vs IX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IX Overall Edge

IX Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ORIX Corporation American Depositary Shares (each representing One (1) Share of Common Stock) (IX) driven by superior Valuation, Momentum & Technical while NMR counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, NMR trades at 12.7x Forward P/E with 25.1% operating margin (+17.9% YoY revenue) versus IX at 12.4x Forward P/E and 20.5% operating margin (+2.1% YoY). In options structure, NMR sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against IX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner IX
NMR 12.7x vs IX 12.4x Fwd P/E
Growth & Margin Winner NMR
Op Margin 25.1% vs 20.5% ยท YoY +17.9% vs +2.1%
Momentum & Technical Winner IX
1Y +26.3% vs +26.5% ยท 52W Pos 60% vs 46%
Options & Structure Winner NMR
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
NMR NYSE
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.74% 1D
Market Cap $28.3B
1M Return +2.36%
1Y Return +26.32%
Forward P/E 12.7x
Unified AI Score
44.5 / 100 HOLD
Tech 47.0 Fund 49.0 Flow 50.0 Mom 50.0
IX NYSE
ORIX Corporation American Depositary Shares (each representing One (1) Share of Common Stock)
Miscellaneous Business Credit Institution
$33.19
-1.31% 1D
Market Cap $36.9B
1M Return -9.12%
1Y Return +26.53%
Forward P/E 12.4x
Unified AI Score
47.5 / 100 HOLD
Tech 52.0 Fund 47.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NMR +26.32% IX +26.53% Spread: +0.21 pp (IX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NMR TTM Op. Margin: 25.1% IX TTM Op. Margin: 20.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs IX. Trailing 12-month operating profitability (NMR 25.1% vs IX 20.5%) and valuation multiples (NMR 12.7x vs IX 12.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NMR (3) vs IX (7)
Institutional Metric NMR IX Criterion Row Winner
Market Capitalization Scale $28.3B $36.9B Larger Scale IX
Trailing P/E Ratio Valuation 11.2x 6.3x Lower Multiple IX
Forward P/E Ratio Valuation 12.7x 12.4x Lower Multiple IX
Revenue Growth (YoY) Growth +17.9% +2.1% Higher Growth NMR
Operating Margin (TTM) Profitability 25.1% 20.5% Higher Margin NMR
Net Profit Margin Profitability 17.1% 29.7% Higher Margin IX
Return on Equity (ROE) Capital Efficiency 11.5% 19.7% Higher ROE IX
52-Week Range Position Momentum 60% ($7โ€“$11) 46% ($25โ€“$42) Stronger Trend NMR
Beta / 30D Volatility Risk Regime 1.03ฮฒ ยท 29% Vol 0.98ฮฒ ยท 27% Vol Lower Realized Risk IX
Unified Institutional Score Composite Signal 44.5 / 100 (HOLD) 47.5 / 100 (HOLD) Higher Composite IX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NMR vs IX Buy Guide
NMR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live NMR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live IX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NMR nor IX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.